Human papillomavirus status and gene expression profiles of oropharyngeal and oral cancers from European American and African American patients

Head and Neck

Volumn 38, Issue , 2016, Pages E694-E704

  Tomar, Swati ^a   Graves, Christian A ^a   Altomare, Diego ^b   Kowli, Sangeeta ^a   Kassler, Susannah ^b   Sutkowski, Natalie ^c   Gillespie, M Boyd ^c   Creek, Kim E ^b   Pirisi, Lucia ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

African American; cancer health disparities; gene expression; head and neck cancer; human papillomavirus (HPV)

Indexed keywords

BRCA1 PROTEIN; COLLAGENASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 2A; MINICHROMOSOME MAINTENANCE PROTEIN 2; PROTEIN P53; STROMELYSIN 2; TRANSFORMING GROWTH FACTOR BETA2; VIRUS DNA; VIRUS MESSENGER RNA; TRANSCRIPTOME;

ADAM12 GENE; ADULT; AFRICAN AMERICAN; ALCOHOL CONSUMPTION; ANGIOGENESIS; ARTICLE; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER PATIENT; CDKN2A GENE; CELL CYCLE CHECKPOINT; CELL MOTILITY; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; EUROPEAN AMERICAN; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KRT15 GENE; MAL GENE; MALE; MET GENE; MIDDLE AGED; MINICHROMOSOME MAINTENANCE PROTEIN 2 GENE; MITOSIS; MMP10 GENE; MMP13 GENE; MOUTH CANCER; MOUTH CAVITY; NONHUMAN; ONCOGENE; OPEN READING FRAME; OROPHARYNX CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RACE DIFFERENCE; SMOKING; TP53 GENE; TRANSFORMING GROWTH FACTOR BETA2 GENE; TUMOR SUPPRESSOR GENE; VIRAL GENETICS; VIRUS ACTIVATION; VIRUS ONCOGENE; WART VIRUS; AGED; CAUCASIAN; COMPLICATION; ETHNOLOGY; GENETICS; MOUTH TUMOR; OROPHARYNX TUMOR; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; SOUTH CAROLINA; SQUAMOUS CELL CARCINOMA; VIROLOGY;

AFRICAN AMERICANS; AGED; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SOUTH CAROLINA; TRANSCRIPTOME;

EID: 84930894952     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.24072     Document Type: Article

References (49)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Curado MP, Boyle P,. Epidemiology of head and neck squamous cell carcinoma not related to tobacco or alcohol. Curr Opin Oncol 2013; 25: 229-234.
3. Joseph AW, D'Souza G,. Epidemiology of human papillomavirus-related head and neck cancer. Otolaryngol Clin North Am 2012; 45: 739-764.
4. Weinberger PM, Yu Z, Haffty BG, et al., Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24: 736-747.
5. Cardesa A, Nadal A,. Carcinoma of the head and neck in the HPV era. Acta Dermatovenerol Alp Panonica Adriat 2011; 20: 161-173.
6. Gillison ML, D'Souza G, Westra W, et al., Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008; 100: 407-420.
7. Beachler DC, D'Souza G,. Oral human papillomavirus infection and head and neck cancers in HIV-infected individuals. Curr Opin Oncol 2013; 25: 503-510.
8. Yen KL, Horner MJ, Reed SG, et al., Head and neck cancer disparities in South Carolina: descriptive epidemiology, early detection, and special programs. J S C Med Assoc 2006; 102: 192-200.
9. Andersen AS, Koldjaer Sølling AS, Ovesen T, Rusan M,. The interplay between HPV and host immunity in head and neck squamous cell carcinoma. Int J Cancer 2014; 134: 2755-2763.
10. Werness BA, Münger K, Howley PM,. Role of the human papillomavirus oncoproteins in transformation and carcinogenic progression. Important Adv Oncol 1991: 3-18.
11. Al-Bakkal G, Ficarra G, McNeill K, Eversole LR, Sterrantino G, Birek C,. Human papilloma virus type 16 E6 gene expression in oral exophytic epithelial lesions as detected by in situ rtPCR. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87: 197-208.
12. Campisi G, Panzarella V, Giuliani M, et al., Human papillomavirus: its identity and controversial role in oral oncogenesis, premalignant and malignant lesions (review). Int J Oncol 2007; 30: 813-823.
13. Li Y, Nichols MA, Shay JW, Xiong Y,. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 1994; 54: 6078-6082.
14. Klaes R, Friedrich T, Spitkovsky D, et al., Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92: 276-284.
15. Wilson DD, Rahimi AS, Saylor DK, et al., p16 not a prognostic marker for hypopharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2012; 138: 556-561.
16. Deng Z, Hasegawa M, Kiyuna A, et al., Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma. Head Neck 2013; 35: 800-808.
17. Zandberg DP, Liu S, Goloubeva O, et al., Oropharyngeal cancer (OPC) drives racial outcome disparities in squamous cell carcinoma of the head and neck (HNSCC): ten year experience at the University of Maryland Greenebaum Cancer Center (UMGCC). Head Neck 2014. [Epub ahead of print].
18. Brawley OW,. Oropharyngeal cancer, race, and the human papillomavirus. Cancer Prev Res (Phila) 2009; 2: 769-772.
19. Cole L, Polfus L, Peters ES,. Examining the incidence of human papillomavirus-associated head and neck cancers by race and ethnicity in the U.S., 1995-2005. PLoS One 2012; 7: e32657.
20. Murdock JM, Gluckman JL,. African-American and white head and neck carcinoma patients in a university medical center setting. Are treatments provided and are outcomes similar or disparate? Cancer 2001; 91 (1 Suppl): 279-283.
21. Weinberger PM, Merkley MA, Khichi SS, et al., Human papillomavirus-active head and neck cancer and ethnic health disparities. Laryngoscope 2010; 120: 1531-1537.
22. Slebos RJ, Yi Y, Ely K, et al., Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res 2006; 12 (3 Pt 1): 701-709.
23. Smeets SJ, Braakhuis BJ, Abbas S, et al., Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene 2006; 25: 2558-2564.
24. Kostareli E, Holzinger D, Bogatyrova O, et al., HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas. J Clin Invest 2013; 123: 2488-2501.
25. Stransky N, Egloff AM, Tward AD, et al., The mutational landscape of head and neck squamous cell carcinoma. Science 2011; 333: 1157-1160.
26. Agrawal N, Frederick MJ, Pickering CR, et al., Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011; 333: 1154-1157.
27. Roberts SA, Lawrence MS, Klimczak LJ, et al., An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet 2013; 45: 970-976.
28. Khoury JD, Tannir NM, Williams MD, et al., Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J Virol 2013; 87: 8916-8926.
29. Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL,. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 2012; 13: 134.
30. Bustin SA, Benes V, Garson JA, et al., The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009; 55: 611-622.
31. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J,. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 2007; 8: R19.
32. Pyeon D, Newton MA, Lambert PF, et al., Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res 2007; 67: 4605-4619.
33. Schlecht NF, Burk RD, Adrien L, et al., Gene expression profiles in HPV-infected head and neck cancer. J Pathol 2007; 213: 283-293.
34. Chung CH, Parker JS, Karaca G, et al., Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 2004; 5: 489-500.
35. Schache AG, Liloglou T, Risk JM, et al., Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Clin Cancer Res 2011; 17: 6262-6271.
36. Holzinger D, Flechtenmacher C, Henfling N, et al., Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway. Int J Cancer 2013; 133: 1389-1399.
37. Settle K, Posner MR, Schumaker LM, et al., Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila) 2009; 2: 776-781.
38. Chernock RD, Zhang Q, El-Mofty SK, Thorstad WL, Lewis JS Jr,. Human papillomavirus-related squamous cell carcinoma of the oropharynx: a comparative study in whites and African Americans. Arch Otolaryngol Head Neck Surg 2011; 137: 163-169.
39. Worsham MJ, Stephen JK, Chen KM, et al., Improved survival with HPV among African Americans with oropharyngeal cancer. Clin Cancer Res 2013; 19: 2486-2492.
40. Jung AC, Job S, Ledrappier S, et al., A poor prognosis subtype of HNSCC is consistently observed across methylome, transcriptome, and miRNome analysis. Clin Cancer Res 2013; 19: 4174-4184.
41. Johannsen E, Lambert PF,. Epigenetics of human papillomaviruses. Virology 2013; 445: 205-212.
42. Koontongkaew S,. The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas. J Cancer 2013; 4: 66-83.
43. Rao VH, Kandel A, Lynch D, et al., A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion. Oncogene 2012; 31: 2888-2898.
44. Lallemant B, Evrard A, Combescure C, et al., Reference gene selection for head and neck squamous cell carcinoma gene expression studies. BMC Mol Biol 2009; 10: 78.
45. Dudás J, Fullár A, Bitsche M, et al., Tumor-produced, active interleukin-1β regulates gene expression in carcinoma-associated fibroblasts. Exp Cell Res 2011; 317: 2222-2229.
46. Kamatani T, Shiogama S, Yoshihama Y, Kondo S, Shirota T, Shintani S,. Interleukin-1 beta in unstimulated whole saliva is a potential biomarker for oral squamous cell carcinoma. Cytokine 2013; 64: 497-502.
47. Cao W, Zhang ZY, Xu Q, et al., Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma. Mol Cancer 2010; 9: 296.
48. Burtness B, Bauman JE, Galloway T,. Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition. Lancet Oncol 2013; 14: e302-e309.
49. + cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis. Int J Cancer 2011; 129: 2337-2348.